VAGISIL Anti-Itch Medicated Creme Maximum Strength

Manufacturer: Combe Incorporated
Effective date: 2024-12-12
Label type: HUMAN OTC DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-06-01 00:41:41

Label at a glance#

ProductVAGISIL Anti-Itch Medicated Creme Maximum Strength

Active ingredientBENZOCAINE, RESORCINOL

Label structure13 sections

Dosage and administration

adults and children 12 years and older Apply a fingertip amount (approximately 1-inch strip) to affected area not more than 3 to 4 times daily. Clean nozzle of tube by wiping thoroughly before replacing cap. Keep cap tightly closed between uses. children under 12 years consult a doctor

Contacts and useful links#

PhoneLabel contact1-800-431-2610

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

VAGISIL Maximum Strength Anti-Itch Creme

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzocaine 20%

Purpose

OTC - PURPOSE SECTION

External analgesic

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Resorcinol 3%

Purpose

OTC - PURPOSE SECTION

External analgesic

Use

INDICATIONS & USAGE SECTION

temporarily relieves itching

Warnings

WARNINGS SECTION

For external use only

Allergy Allert

Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other –caine anesthetics.

Avoid contact with eyes

in case of contact rinse thoroughly and immediately with water.

Stop use and ask doctor if

OTC - STOP USE SECTION

condition worsens, or if symptoms persist for more than 7 days, or clear up and occur again within a few days

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and older	Apply a fingertip amount (approximately 1-inch strip) to affected area not more than 3 to 4 times daily. Clean nozzle of tube by wiping thoroughly before replacing cap. Keep cap tightly closed between uses.
children under 12 years	consult a doctor

Other Information:

OTHER SAFETY INFORMATION

questions? call 1-800-431-2610, 9 am to 5 pm est

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Mineral Oil, Cetyl Alcohol, Propylene Glycol, Glyceryl Stearate, PEG-100 Stearate, Isopropyl Palmitate, Aloe Barbadensis Leaf Extract, Tocopheryl Acetate, Retinyl Palmitate, Zea Mays (Corn) Oil, Cholecalciferol, Lanolin Alcohol, Fragrance, Methylparaben, Carbomer, Isopropyl Myristate, Isopropyl Stearate, Sodium Sulfite, Triethanolamine, Trisodium HEDTA, Maltodextrin

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Vagisil_®
Maximum Strength
Anti-Itch Creme

Net Wt. 1 oz. (28 g)

Principal Display Panel Vagisil® Maximum Strength Anti-Itch Creme Net Wt. 1 oz. (28 g)

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1247441	VAGISIL ORIGINAL FORMULA (Vaginal)	benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream [Vagisil Original Formula]	SBD Active

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
637518	benzocaine 20 % / resorcinol 3 % Vaginal Cream	PSN	9
1247441	Vagisil Maximum Strength 20 % / 3 % Vaginal Cream	PSN	9
1247441	benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream [Vagisil Original Formula]	SBD	9
637518	benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream	SCD	9
637518	benzocaine 20 % / resorcinol 3 % Vaginal Cream	SY	9
1247441	Vagisil Maximum Strength (benzocaine 20 % / resorcinol 3 % ) Vaginal Cream	SY	9
1247441	Vagisil, Maximum Strength, Anti-Itch Topical Cream	SY	9

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BENZOCAINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
60c52429-fcef-eb54-2387-43bc9e4f296b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
11509-4402-1	2020-04-20	C162847	48780-1	9d75b9d0-ed22-f424-e053-dadaa90a57ce	Vagisil Maximum Strength Anti-Itch Creme
11509-4402-1	2020-01-31	C162847	48780-1	9d75b9d0-ed22-f424-e053-dadaa90a57ce	Vagisil Maximum Strength Anti-Itch Creme

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
11509-4402-1	VAGISIL Anti-Itch Medicated Creme Maximum Strength	1 in 1 CARTON	CREAM	1		9
11509-4402-1	VAGISIL Anti-Itch Medicated Creme Maximum Strength	28 g in 1 TUBE	CREAM	28		9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11509-4402	VAGISIL ANTI-ITCH MEDICATED CREME MAXIMUM STRENGTH (BENZOCAINE AND RESORCINOL) CREAM [COMBE INCORPORATED]	9	Current NDC, Legacy NDC, 2 package rows	20241211_bb73ebd7-ceb0-4b54-9e8f-77486d9037fb.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
11509-4402-1	GM - Gram	11509-4402	220844e9-5407-48f4-922a-790ee69a58f4	1	2022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BENZOCAINE	ACTIVE INGREDIENT	U3RSY48JW5	4
RESORCINOL	ACTIVE INGREDIENT	YUL4LO94HK	4
BENZOCAINE	ACTIVE MOIETY	U3RSY48JW5	4
RESORCINOL	ACTIVE MOIETY	YUL4LO94HK	4
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	4
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	4
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	HHT01ZNK31	4
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	4
CHOLECALCIFEROL	INACTIVE INGREDIENT	1C6V77QF41	4
CORN OIL	INACTIVE INGREDIENT	8470G57WFM	4
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	4
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	4
ISOPROPYL PALMITATE	INACTIVE INGREDIENT	8CRQ2TH63M	4
ISOPROPYL STEARATE	INACTIVE INGREDIENT	43253ZW1MZ	4
LANOLIN ALCOHOLS	INACTIVE INGREDIENT	884C3FA9HE	4
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	4
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	4
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	4
SODIUM SULFITE	INACTIVE INGREDIENT	VTK01UQK3G	4
TRISODIUM HEDTA	INACTIVE INGREDIENT	K3E0U7O8KI	4
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	4
VITAMIN A PALMITATE	INACTIVE INGREDIENT	1D1K0N0VVC	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

VAGISIL Anti-Itch Medicated Creme Maximum Strength
Benzocaine and Resorcinol
BENZOCAINE
RESORCINOL
WATER
MINERAL OIL
CETYL ALCOHOL
PROPYLENE GLYCOL
GLYCERYL MONOSTEARATE
PEG-100 STEARATE
ISOPROPYL PALMITATE
ALOE VERA LEAF
ALPHA-TOCOPHEROL ACETATE
VITAMIN A PALMITATE
CORN OIL
CHOLECALCIFEROL
LANOLIN ALCOHOLS
METHYLPARABEN
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
ISOPROPYL MYRISTATE
ISOPROPYL STEARATE
SODIUM SULFITE
TROLAMINE
TRISODIUM HEDTA
MALTODEXTRIN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
11509-4402	11509-4402-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BENZOCAINE	U3RSY48JW5	ACTIB
RESORCINOL	YUL4LO94HK	ACTIB
WATER	059QF0KO0R	IACT
MINERAL OIL	T5L8T28FGP	IACT
CETYL ALCOHOL	936JST6JCN	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
GLYCERYL MONOSTEARATE	230OU9XXE4	IACT
PEG-100 STEARATE	YD01N1999R	IACT
ISOPROPYL PALMITATE	8CRQ2TH63M	IACT
ALOE VERA LEAF	ZY81Z83H0X	IACT
ALPHA-TOCOPHEROL ACETATE	9E8X80D2L0	IACT
VITAMIN A PALMITATE	1D1K0N0VVC	IACT
CORN OIL	8470G57WFM	IACT
CHOLECALCIFEROL	1C6V77QF41	IACT
LANOLIN ALCOHOLS	884C3FA9HE	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	HHT01ZNK31	IACT
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
ISOPROPYL STEARATE	43253ZW1MZ	IACT
SODIUM SULFITE	VTK01UQK3G	IACT
TROLAMINE	9O3K93S3TK	IACT
TRISODIUM HEDTA	K3E0U7O8KI	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 66 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET / ORAL		320 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	TABLET / ORAL	0.5 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET / ORAL		320 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
CORN OIL	CORN OIL	8470G57WFM	CREAM / TOPICAL	NA		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SODIUM SULFITE	SODIUM SULFITE	VTK01UQK3G	CREAM / TOPICAL		8 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	SUSPENSION / ORAL		6040 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, EFFERVESCENT / ORAL		14404 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	CREAM / TOPICAL		112 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	CREAM / TOPICAL		836 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	PASTE / ORAL		1050 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, ORALLY DISINTEGRATING / ORAL		12 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, EXTENDED RELEASE / ORAL		3239 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	FILM, SOLUBLE / ORAL		19 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
TRISODIUM HEDTA	TRISODIUM HEDTA	K3E0U7O8KI	SOLUTION / TOPICAL	0.4 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	GRANULE, FOR SUSPENSION / ORAL		952 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
PEG-100 STEARATE	PEG-100 MONOSTEARATE	YD01N1999R	CREAM / TOPICAL		552 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SODIUM SULFITE	SODIUM SULFITE	VTK01UQK3G	CREAM / TOPICAL		8 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, COATED / ORAL	5.6 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
TRISODIUM HEDTA	TRISODIUM HEDTA	K3E0U7O8KI	SOAP / TOPICAL	0.4 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	CAPSULE / ORAL	2 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	HHT01ZNK31	CREAM / TOPICAL		214 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / TOPICAL		3000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	SUSPENSION / ORAL		6040 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	FILM / BUCCAL	0.09 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	CAPSULE / ORAL		200 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, ORALLY DISINTEGRATING / ORAL		12 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	FILM, SOLUBLE / ORAL		19 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	POWDER, FOR SUSPENSION / ORAL		8000 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	CREAM / TOPICAL	1 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CREAM / TOPICAL		3000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
TRISODIUM HEDTA	TRISODIUM HEDTA	K3E0U7O8KI	SOLUTION / TOPICAL	0.4 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	TABLET / ORAL	0.5 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	CREAM / TOPICAL	1 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	CREAM / TOPICAL		836 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
TRISODIUM HEDTA	TRISODIUM HEDTA	K3E0U7O8KI	SOAP / TOPICAL	0.4 %w/w		Exact identifier — unii+route 4 equally ranked IID candidates
MINERAL OIL	MINERAL OIL	T5L8T28FGP	CREAM / TOPICAL		2772 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	CREAM / TOPICAL		65000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PEG-100 STEARATE	PEG-100 MONOSTEARATE	YD01N1999R	CREAM / TOPICAL		552 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE	.ALPHA.-TOCOPHEROL ACETATE	9E8X80D2L0	CAPSULE / ORAL	2 mg		Exact identifier — unii candidate 6 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM / TOPICAL		76000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LANOLIN ALCOHOLS	LANOLIN ALCOHOLS	884C3FA9HE	CREAM / TOPICAL	6 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	HHT01ZNK31	CREAM / TOPICAL		214 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, COATED / ORAL	5.6 mg		Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	CAPSULE / ORAL		200 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	POWDER, FOR SUSPENSION / ORAL		8000 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, EFFERVESCENT / ORAL		14404 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, EXTENDED RELEASE / ORAL		3239 mg	Exact identifier — unii candidate 30 equally ranked IID candidates
ISOPROPYL PALMITATE	ISOPROPYL PALMITATE	8CRQ2TH63M	CREAM / TOPICAL		112 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM / TOPICAL		76000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VAGISIL Anti-Itch Medicated Creme Maximum Strength	BENZOCAINE AND RESORCINOL	Combe Incorporated	bb73ebd7-ceb0-4b54-9e8f-77486d9037fb	2024-12-12	Warnings	Exact identifier ndc (package): 11509-4402-1 ndc (product): 11509-4402 ndc11 (package): 11509440201 spl id: c2295da1-a600-4d65-98b2-6c81fb08c6c0 spl set id: bb73ebd7-ceb0-4b54-9e8f-77486d9037fb

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

VAGISIL Anti-Itch Medicated Creme Maximum Strength

Label at a glance#

Dosage and administration

Contacts and useful links#

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Active ingredient

Purpose

Active ingredient

Purpose

Use

Warnings

Stop use and ask doctor if

Keep out of reach of children.

Directions

Other Information:

Inactive ingredients

Principal Display Panel

Related RxNorm Concepts#

DailyMed RxNorm Mappings#

DailyMed Pharmacologic Classes#

DailyMed Product Concepts#

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

DailyMed Dashboard NDC Coverage#

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Products#

NDC Codes#

Ingredients#

Source Document#

Inactive ingredient matches#

openFDA label cross-check#

Reported adverse events (FAERS/openFDA)#